Opus Genetics, Stock Today
| IRD Stock | 1.08 0.01 0.93% |
PerformanceSoft
| Odds Of DistressRisky
|
Opus Genetics, is trading at 1.08 as of the 5th of August 2025, a 0.93% up since the beginning of the trading day. The stock's lowest day price was 1.07. Opus Genetics, has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Opus Genetics, symbol was changed from OCUP on 24th of October 2024. The performance scores are derived for the period starting the 7th of May 2025 and ending today, the 5th of August 2025. Click here to learn more.
Moving together with Opus Stock
Opus Stock Highlights
| Older Symbol | OCUP |
| CEO Director | MBA MD |
| Old Name | Groupe IRD |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Opus Genetics, (IRD) is traded on NASDAQ Exchange in USA. It is located in 8 Davis Drive, Durham, NC, United States, 27709 and employs 18 people. Opus Genetics, was previously known as OCUP Old and was traded on NASDAQ Exchange under the symbol OCUP. Opus Genetics, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 35.67 M. Opus Genetics, runs under Pharmaceuticals sector within Health Care industry. The entity has 31.57 M outstanding shares of which 495.95 K shares are currently shorted by investors with about 3.44 days to cover.
Opus Genetics, generates negative cash flow from operations
Check Opus Genetics, Probability Of Bankruptcy
Ownership AllocationOpus Genetics, owns a total of 31.57 Million outstanding shares. Opus Genetics, holds 16.14 pct. of its outstanding shares held by insiders and 16.64 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Opus Ownership Details
Opus Genetics, Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Opus Genetics, market risk premium is the additional return an investor will receive from holding Opus Genetics, long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0427 | |||
| Jensen Alpha | 0.1358 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0057 |
Opus Stock Against Markets
Opus Genetics, Corporate Management
| Joseph MBA | Chief Officer | Profile | |
| Bernhard MBA | Senior Secretary | Profile | |
| Ashwath Jayagopal | Chief Officer | Profile | |
| Bindu Manne | Head Commercialization | Profile | |
| MAcc CPA | Principal Officer | Profile | |
| Nirav CFA | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.